NEW YORK (Reuters Health) – HIV patients whose regimen includes efavirenz and who experience CNS side effects such as insomnia and nervousness may benefit from a switch to…
NEW YORK (Reuters Health) – Anemia that develops in hepatitis C virus (HCV) patients during treatment with peginterferon-alfa and ribavirin (PEG-IFN/RBV) may be a good sign, new research…
NEW YORK (Reuters Health) – Vaccinating pregnant women against influenza is a highly effective way of keeping their infants from being hospitalized with influenza in the first six…
NEW YORK (Reuters Health) – In 2009, people given the seasonal trivalent influenza vaccine were at higher risk of infection with the pandemic H1N1 strain than those given…
NEW YORK (Reuters Health) – Cure rates are similar when patients hospitalized with community-acquired pneumonia are treated with ceftaroline or ceftriaxone — but ceftaroline may have the edge,…
NEW YORK (Reuters Health) – The characteristic loss of facial fat in many patients being treated for HIV infection can be effectively rectified with autologous fat transplantation or…
NEW YORK (Reuters Health) – Results of in vitro testing indicate that silver impregnation of urinary catheters has little effect on bacterial adherence, reinforcing findings from clinical studies…
NEW YORK (Reuters Health) – Chronic Chagas disease in the elderly doubles their risk of dying from a stroke, and the risk is increased further in those with…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
NEW YORK (Reuters Health) – For patients with advanced HIV disease –either AIDS or a CD4 count below 200 — initial antiretroviral regimens based on efavirenz or ritonavir-boosted…